Institutional shares held 29.1 Million
305K calls
192K puts
Total value of holdings $6.99B
$73.3M calls
$46.1M puts
Market Cap $9.11B
37,888,400 Shares Out.
Institutional ownership 76.72%
# of Institutions 373


Latest Institutional Activity in PEN

Top Purchases

Q3 2024
Janus Henderson Group PLC Shares Held: 669K ($161M)
Q3 2024
Thrivent Financial For Lutherans Shares Held: 368K ($88.6M)
Q3 2024
Citadel Advisors LLC Shares Held: 412K ($99.1M)
Q3 2024
Champlain Investment Partners, LLC Shares Held: 1.55M ($372M)
Q3 2024
Massachusetts Financial Services CO Shares Held: 165K ($39.6M)

Top Sells

Q3 2024
Price T Rowe Associates Inc Shares Held: 1.99M ($478M)
Q3 2024
Goldman Sachs Group Inc Shares Held: 287K ($69M)
Q3 2024
Marshall Wace, LLP Shares Held: 1.82K ($438K)
Q3 2024
Baird Financial Group, Inc. Shares Held: 195K ($46.8M)
Q3 2024
Millennium Management LLC Shares Held: 5.25K ($1.26M)

About PEN

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.


Insider Transactions at PEN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
32.6K Shares
From 13 Insiders
Grant, award, or other acquisition 19.9K shares
Exercise of conversion of derivative security 12.7K shares
Sell / Disposition
212K Shares
From 11 Insiders
Open market or private sale 138K shares
Payment of exercise price or tax liability 3.64K shares
Bona fide gift 69.9K shares

Track Institutional and Insider Activities on PEN

Follow Penumbra Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PEN shares.

Notify only if

Insider Trading

Get notified when an Penumbra Inc insider buys or sells PEN shares.

Notify only if

News

Receive news related to Penumbra Inc

Track Activities on PEN